Cargando…

T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease

In the current study, we have evaluated the performance of magnetic resonance (MR) T1rho (T(1ρ)) imaging and CSF biomarkers (T-tau, P-tau and Aβ-42) in characterization of Alzheimer's disease (AD) patients from mild cognitive impairment (MCI) and control subjects. With informed consent, AD (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Haris, Mohammad, Yadav, Santosh K., Rizwan, Arshi, Singh, Anup, Cai, Kejia, Kaura, Deepak, Wang, Ena, Davatzikos, Christos, Trojanowski, John Q., Melhem, Elias R., Marincola, Francesco M., Borthakur, Arijitt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375645/
https://www.ncbi.nlm.nih.gov/pubmed/25844314
http://dx.doi.org/10.1016/j.nicl.2015.02.016
_version_ 1782363608537104384
author Haris, Mohammad
Yadav, Santosh K.
Rizwan, Arshi
Singh, Anup
Cai, Kejia
Kaura, Deepak
Wang, Ena
Davatzikos, Christos
Trojanowski, John Q.
Melhem, Elias R.
Marincola, Francesco M.
Borthakur, Arijitt
author_facet Haris, Mohammad
Yadav, Santosh K.
Rizwan, Arshi
Singh, Anup
Cai, Kejia
Kaura, Deepak
Wang, Ena
Davatzikos, Christos
Trojanowski, John Q.
Melhem, Elias R.
Marincola, Francesco M.
Borthakur, Arijitt
author_sort Haris, Mohammad
collection PubMed
description In the current study, we have evaluated the performance of magnetic resonance (MR) T1rho (T(1ρ)) imaging and CSF biomarkers (T-tau, P-tau and Aβ-42) in characterization of Alzheimer's disease (AD) patients from mild cognitive impairment (MCI) and control subjects. With informed consent, AD (n = 27), MCI (n = 17) and control (n = 17) subjects underwent a standardized clinical assessment and brain MRI on a 1.5-T clinical-scanner. T(1ρ) images were obtained at four different spin-lock pulse duration (10, 20, 30 and 40 ms). T(1ρ) maps were generated by pixel-wise fitting of signal intensity as a function of the spin-lock pulse duration. T(1ρ) values from gray matter (GM) and white matter (WM) of medial temporal lobe were calculated. The binary logistic regression using T(1ρ) and CSF biomarkers as variables was performed to classify each group. T(1ρ) was able to predict 77.3% controls and 40.0% MCI while CSF biomarkers predicted 81.8% controls and 46.7% MCI. T(1ρ) and CSF biomarkers in combination predicted 86.4% controls and 66.7% MCI. When comparing controls with AD, T(1ρ) predicted 68.2% controls and 73.9% AD, while CSF biomarkers predicted 77.3% controls and 78.3% for AD. Combination of T(1ρ) and CSF biomarkers improved the prediction rate to 81.8% for controls and 82.6% for AD. Similarly, on comparing MCI with AD, T(1ρ) predicted 35.3% MCI and 81.9% AD, whereas CSF biomarkers predicted 53.3% MCI and 83.0% AD. Collectively CSF biomarkers and T(1ρ) were able to predict 59.3% MCI and 84.6% AD. On receiver operating characteristic analysis T(1ρ) showed higher sensitivity while CSF biomarkers showed greater specificity in delineating MCI and AD from controls. No significant correlation between T(1ρ) and CSF biomarkers, between T(1ρ) and age, and between CSF biomarkers and age was observed. The combined use of T(1ρ) and CSF biomarkers have promise to improve the early and specific diagnosis of AD. Furthermore, disease progression form MCI to AD might be easily tracked using these two parameters in combination.
format Online
Article
Text
id pubmed-4375645
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-43756452015-04-03 T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease Haris, Mohammad Yadav, Santosh K. Rizwan, Arshi Singh, Anup Cai, Kejia Kaura, Deepak Wang, Ena Davatzikos, Christos Trojanowski, John Q. Melhem, Elias R. Marincola, Francesco M. Borthakur, Arijitt Neuroimage Clin Regular Article In the current study, we have evaluated the performance of magnetic resonance (MR) T1rho (T(1ρ)) imaging and CSF biomarkers (T-tau, P-tau and Aβ-42) in characterization of Alzheimer's disease (AD) patients from mild cognitive impairment (MCI) and control subjects. With informed consent, AD (n = 27), MCI (n = 17) and control (n = 17) subjects underwent a standardized clinical assessment and brain MRI on a 1.5-T clinical-scanner. T(1ρ) images were obtained at four different spin-lock pulse duration (10, 20, 30 and 40 ms). T(1ρ) maps were generated by pixel-wise fitting of signal intensity as a function of the spin-lock pulse duration. T(1ρ) values from gray matter (GM) and white matter (WM) of medial temporal lobe were calculated. The binary logistic regression using T(1ρ) and CSF biomarkers as variables was performed to classify each group. T(1ρ) was able to predict 77.3% controls and 40.0% MCI while CSF biomarkers predicted 81.8% controls and 46.7% MCI. T(1ρ) and CSF biomarkers in combination predicted 86.4% controls and 66.7% MCI. When comparing controls with AD, T(1ρ) predicted 68.2% controls and 73.9% AD, while CSF biomarkers predicted 77.3% controls and 78.3% for AD. Combination of T(1ρ) and CSF biomarkers improved the prediction rate to 81.8% for controls and 82.6% for AD. Similarly, on comparing MCI with AD, T(1ρ) predicted 35.3% MCI and 81.9% AD, whereas CSF biomarkers predicted 53.3% MCI and 83.0% AD. Collectively CSF biomarkers and T(1ρ) were able to predict 59.3% MCI and 84.6% AD. On receiver operating characteristic analysis T(1ρ) showed higher sensitivity while CSF biomarkers showed greater specificity in delineating MCI and AD from controls. No significant correlation between T(1ρ) and CSF biomarkers, between T(1ρ) and age, and between CSF biomarkers and age was observed. The combined use of T(1ρ) and CSF biomarkers have promise to improve the early and specific diagnosis of AD. Furthermore, disease progression form MCI to AD might be easily tracked using these two parameters in combination. Elsevier 2015-02-26 /pmc/articles/PMC4375645/ /pubmed/25844314 http://dx.doi.org/10.1016/j.nicl.2015.02.016 Text en © 2015 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Haris, Mohammad
Yadav, Santosh K.
Rizwan, Arshi
Singh, Anup
Cai, Kejia
Kaura, Deepak
Wang, Ena
Davatzikos, Christos
Trojanowski, John Q.
Melhem, Elias R.
Marincola, Francesco M.
Borthakur, Arijitt
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
title T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
title_full T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
title_fullStr T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
title_full_unstemmed T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
title_short T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
title_sort t1rho mri and csf biomarkers in diagnosis of alzheimer's disease
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375645/
https://www.ncbi.nlm.nih.gov/pubmed/25844314
http://dx.doi.org/10.1016/j.nicl.2015.02.016
work_keys_str_mv AT harismohammad t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT yadavsantoshk t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT rizwanarshi t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT singhanup t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT caikejia t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT kauradeepak t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT wangena t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT davatzikoschristos t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT trojanowskijohnq t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT melhemeliasr t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT marincolafrancescom t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease
AT borthakurarijitt t1rhomriandcsfbiomarkersindiagnosisofalzheimersdisease